Ely Benaim
Keine laufenden Positionen mehr
Vermögen: 351 857 $ am 30.04.2024
Karriereverlauf von Ely Benaim
Ehemalige bekannte Positionen von Ely Benaim
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| NOVOCURE LIMITED | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2019 | 17.01.2023 |
| REXAHN PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2015 | 31.03.2019 |
| Berg Pharma LLC | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2013 | 01.01.2015 |
| General Counsel | 01.01.2013 | 01.01.2015 | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2011 | 01.01.2013 |
| SANGAMO THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2007 | 01.01.2010 |
| University of Tennessee | Corporate Officer/Principal | - | - |
Salmedix, Inc.
 Salmedix, Inc. Pharmaceuticals: MajorHealth Technology Salmedix, Inc. develops oncology and small molecule drugs to treat hematological malignancies. The company's product, Treanda, is currently in Phase II clinical trials in the United States and Canada for the treatment of indolent (slowly progressing) non-Hodgkin's lymphoma. It was founded in 2000 and is located in San Diego, CA. | Corporate Officer/Principal | - | - |
Ausbildung von Ely Benaim
| Central University of Venezuela | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
| Venezuela | 2 |
| Vereinigtes Königreich | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 5 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| NOVOCURE LIMITED | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Salmedix, Inc.
Salmedix, Inc. Pharmaceuticals: MajorHealth Technology Salmedix, Inc. develops oncology and small molecule drugs to treat hematological malignancies. The company's product, Treanda, is currently in Phase II clinical trials in the United States and Canada for the treatment of indolent (slowly progressing) non-Hodgkin's lymphoma. It was founded in 2000 and is located in San Diego, CA. | Health Technology |
Rexahn Pharmaceuticals, Inc.
 Rexahn Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rexahn Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics. Its drug candidates include the following: RX-31171 for pancreatic, bladder, colon, and lung cancer; and RX-5902 for metastatic triple negative breast cancer. The company was founded by Chang Ho Ahn on March 19, 2001 and is headquartered in Rockville, MD. | Health Technology |
| Berg Pharma LLC |
- Börse
- Insiders
- Ely Benaim
- Erfahrung
